Further Reading
Cabassu J, Seim H, MacPhail C, Monnet E.
Outcomes of cats undergoing surgical attenuation of congenital extrahepatic portosystemic shunts through cellophane banding: 9 cases (2000-2007).
Journal of the American Veterinary Medical Association. 2011; 238(1): 89-93.Caporali EH, Phillips H, Underwood L, Selmic, LE. Risk factors for urolithiasis in dogs with congenital extrahepatic portosystemic shunts: 95 cases (1999-2013). Journal of the American Veterinary Medical Association. 2015; 246(5): 530-536.
Fryer K, Levine J, Peycke L, Thompson J, Cohen N. Incidence of postoperative seizures with and without levetiracetam pretreatment in dogs undergoing portosystemic shunt attenuation. Journal of Veterinary Internal Medicine. 2011; 25(60): 1379-1384.
Mankin KM. Current concepts in congenital portosystemic shunts. The Veterinary Clinics of North America: Small Animal Practice. 2015; 45(3): 477-487.
Shawcross D, Jalan R. Dispelling myths in the treatment of hepatitic encephalopathy. Lancet, 2005; 365(9457): 431-433.
Weisse C, Berent A, Todd K, Solomon J, Cope C. Endovascular evaluation and treatment of intrahepatic portosystemic shunts in dogs: 100 cases (2001-2011). Journal of the American Veterinary Medical Association. 2014; 244(1): 78-94.